Aarti Pharmalabs shares surge 8.8% as Q2 revenue rises 45.93% YoY to Rs610.45 Cr and net profit jumps 156% to Rs71.47 Cr
India, Oct. 29 -- It is an Indian pharmaceutical and life sciences company engaged in manufacturing active pharmaceutical ingredients (APIs), pharmaceutical intermediates and other speciality products. The company serves pharmaceutical customers in domestic and international markets.
The Nifty 50 traded at 22,784.90, up by 0.38%, while the Sensex gained to 73,565.07, up by 0.44%on Thursday. The shares ofAarti Pharmalabsare currently trading at Rs. 955.85, up by 8.83%. The company has a market capitalization of Rs. 8,667.63 crore. The stock's 52 week high is Rs. 1,002.40 and its 52 week low is Rs. 585.00. In the past 6 months, the stock has delivered a return of 34.25%.
What's the News?
Aarti Pharmalabs Limited reported strong consolida...
Click here to read full article from source
To read the full article or to get the complete feed from this publication, please
Contact Us.